Pfizer Inc. (PFE) Increases Earnings Outlook
Pfizer Inc., the world's largest drugmaker, on Thursday raised its earnings guidance for the year and forecast a number of late stage products would emerge from its pipeline in the coming years.
Its shares rose 62 cents, or 2.3 percent, to $27.69 in midday trading in the New York Stock Exchange.
The company raised its adjusted earnings-per-share forecast to a minimum of $2.05, from an earlier forecast of $2. Without adjustments, the company expects earnings at least $1.68 per share.
Analysts surveyed by Thomson Financial expect adjusted earnings per share of $2.02 for the year.
Its shares rose 62 cents, or 2.3 percent, to $27.69 in midday trading in the New York Stock Exchange.
The company raised its adjusted earnings-per-share forecast to a minimum of $2.05, from an earlier forecast of $2. Without adjustments, the company expects earnings at least $1.68 per share.
Analysts surveyed by Thomson Financial expect adjusted earnings per share of $2.02 for the year.
Labels: pfe, Pfizer Inc.
posted by Stock Administrator @ 1:51 PM
0 Comments:
Post a Comment
<< Home